The Trump administration aims to issue a rule empowering regulators to “forcefully” go after companies that don’t share drug ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

Americans pay disproportionately to subsidize pharmaceutical innovation, while the rest of the world benefits and pays less ...

Fixed-income seniors are bearing the brunt of skyrocketing prescription drug prices, according to a shocking new analysis.

UnitedHealth Group shows resilience despite policy and regulatory challenges. Discover why its diversified model and Optum ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic and Wegovy.

President Donald Trump issued an executive order reviving his controversial “Most Favored Nation” (MFN) drug pricing ...

Congressional lawmakers are trading millions in pharmaceutical stocks as the Trump administration vies to overhaul the ...

There are some lines that we should not cross in response to trade tensions—like the tariffs President Trump is expected to ...

Following the attack - the United States' first large-scale strikes on Iran - Trump warned Washington would hit more targets ...

Toy prices are rising at their fastest pace on record, the result of stiff new tariffs in an industry where 3 out of 4 items ...